MTOR and renal cell carcinoma: In conclusion, we identified infiltrating macrophages as a new key player to promote the RCC tumorigenesis and progression and targeting mTOR with rapamycin to suppress CSCs and EMT alteration may help us to develop a new therapy with better efficacy to fight RCC.